Europe strives to increase its biotechnology market presence through security-focused industrial development to achieve global industry leadership.

The biotech market of Europe currently holds a 12% stake in the global industry while attempting to increase its influence through enhanced biosecurity measures. On April 9th 2025 the Centre for Future Generations organized a Euractiv roundtable discussing European biotech industry security aspects. The gathering demonstrated how biosecurity protects business competitiveness together with fueling market-based innovation while reducing risks throughout the biotech industry.

Irene Sacristán Sánchez from the European Commission discussed the necessity of creating regulatory guidelines to measure safety against biotech innovation requirements. She pointed out how biotechnology helps protect biosecurity systems through disease-resistant plant cultivation which strengthens supply chain resistance.

MEP Tomislav Sokol explained that European Union safety regulations enhance market competitiveness and support patient safety as an incentive for biotech industry development. The regulatory system in China brings potential opportunities according to Jeroen Groenewegen-Lau from MERICS and Claire Skentelbery of EuropaBio focuses on biotech for sustaining food security and improving human health globally.

The biotech industry must address new challenges brought by AI-driven technologies according to Velislava Petrova from the Centre for Future Generations because proactive regulations are required to achieve safe innovative biotech advancements. European biosecurity standards play a vital role in shaping Europecan biotech industry performance within the global biotechnology sector.